Related Articles
Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome‑mediated degradation of epidermal growth factor receptor
Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells
Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis
Establishment and characterization of a triple negative basal‑like breast cancer cell line with multi‑drug resistance
Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathways